Sanket Dhruva, MD
Assistant Professor
Education
Publications
Rathi VK, Ross JS, Redberg RF, Dhruva SS. Medical Device User Fee Reauthorization - Back to Basics or Looking Ahead? 2022. PMID: 35675195
Hidano D, Dhruva SS, Redberg RF. US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019. 2022. PMID: 35286367
Muniyappa AN, Raitt MH, Judson GL, Shen H, Tarasovsky G, Whooley MA, Dhruva SS. Factors Associated with Remote Monitoring Adherence for Cardiovascular Implantable Electronic Devices. 2022. PMID: 35500792
Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF. Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi Panel. 2022. PMID: 35292958
Dhruva SS, Zeitler EP, Caños D, Odobasic H, Major JM, Wang L, Mullane S, Nabutovsky Y, Smith V, Zhang L, Selzman KA. Evaluation of cardiovascular implantable electronic device leads post implant: ElectroPhysiology Predictable And SuStainable Implementation Of National Registries (EP PASSION). 2022. PMID: 35334060
Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF. Experts' Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care. 2022. PMID: 35138547
Money NM, Schroeder AR, Quinonez RA, Ho T, Marin JR, Wolf ER, Morgan DJ, Dhruva SS, Coon ER. 2021 Update on Pediatric Overuse. 2022. PMID: 35059726
Zhou T, Liu P, Dhruva SS, Shah ND, Ramachandran R, Berg KM, Ross JS. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019. 2022. PMID: 34982097
Liebeskind AY, Chen AC, Dhruva SS, Sedrakyan A. A 510(k) ancestry of robotic surgical systems. 2022. PMID: 35032697
Dhruva SS, Shah ND, Vemulapalli S, Deshmukh A, Beatty AL, Gamble GM, Freeman JV, Hummel JP, Piccini JP, Akar JG, Ervin K, Arges KL, Emanuel L, Noseworthy PA, Hu T, Bartlett V, Ross JS. Heart Watch Study: protocol for a pragmatic randomised controlled trial. 2021. PMID: 35234659
Dhruva SS, Jiang G, Doshi AA, Friedman DJ, Brandt E, Chen J, Akar JG, Ross JS, Ervin KR, Collison Farr K, Shah ND, Coplan P, Noseworthy PA, Zhang S, Forsyth T, Schulz WL, Yu Y, Drozda JP. Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center. 2021. PMID: 35047806
Dhruva SS, Redberg RF. Coverage of Transvenous Pulmonary Embolectomy - Medicare's Missed Opportunity for Evidence Generation. 2021. PMID: 34788505
Sturts A, Ruzieh M, Dhruva SS, Peterson B, Mandrola JM, Liu G, Redberg RF, Foy AJ. Resource Utilization Following Coronary Computed Tomographic Angiography and Stress Echocardiography in Patients Presenting to the Emergency Department With Chest Pain. 2021. PMID: 34785035
Huang X, Dhruva SS, Yuan X, Bai X, Lu Y, Yan X, Liu J, Li W, Hu D, Ji R, Gao M, Miao F, Li J, Ge J, Krumholz HM, Li J. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. 2021. PMID: 34732492
Wallach JD, Zhang AD, Skydel JJ, Bartlett VL, Dhruva SS, Shah ND, Ross JS. Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval. 2021. PMID: 34751763
Bartlett VL, Dhruva SS, Shah ND, Ross JS. Clinical studies sponsored by digital health companies participating in the FDA's Precertification Pilot Program: A cross-sectional analysis. 2021. PMID: 34632824
Johnston JL, Dhruva SS, Ross JS, Rathi VK. Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020. 2021. PMID: 34152383
Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment. 2021. PMID: 34677594
Oesterle A, Dhruva SS. Reply to the Editor-Denominator neglect in meta-analysis: electrical abnormalities in St. Jude/Abbott pacing leads. 2021. PMID: 34563689
Jiang G, Dhruva SS, Chen J, Schulz WL, Doshi AA, Noseworthy PA, Zhang S, Yu Y, Patrick Young H, Brandt E, Ervin KR, Shah ND, Ross JS, Coplan P, Drozda JP. Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report. 2021. PMID: 34313748
Lalani C, Kunwar EM, Kinard M, Dhruva SS, Redberg RF. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death. 2021. PMID: 34309624
Khatiwala RV, Mullins E, Fan D, Srivatsa UN, Dhruva SS, Oesterle A. Electrical Abnormalities with St. Jude/Abbott Pacing Leads: A Systematic Review and Meta-analysis. 2021. PMID: 34461304
Mori M, Brooks C, Dhruva SS, Lu Y, Spatz ES, Dey P, Zhang Y, Chaudhry SI, Geirsson A, Allore HG, Krumholz HM. Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment. 2021. PMID: 34304586
Bartlett VL, Ross JS, Shah ND, Ciaccio L, Akar JG, Noseworthy PA, Dhruva SS. Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices. 2021. PMID: 35265911
. Changing FDA Approval Standards: Ethical Implications for Patient Consent. 2021. PMID: 33834346
. Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown? 2021. PMID: 33691059
Holtzman JN, Dhruva SS. Media Portrayals of Extracorporeal Membrane Oxygenation: The Unforeseen Harm of Unfounded Optimism. 2021. PMID: 33393995
Dhruva SS. GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials. 2021. PMID: 33535775
Elliott MH, Skydel JJ, Dhruva SS, Ross JS, Wallach JD. Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019. 2020. PMID: 33226398
Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz AP, Masoudi FA, Messenger JC, Parzynski CS, Ngufor CG, Girotra S, Amin AP, Shah ND, Desai NR. Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. 2021. PMID: 33616664
Liu P, Dhruva SS, Shah ND, Ross JS. Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020. 2021. PMID: 33481031
Akar JG, Hummel JP, Yao X, Sangaralingham L, Dhruva S, Dong J, Ward R, Shah ND, Ross J, Noseworthy PA. Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology. 2020. PMID: 35047796
Johnston JL, Dhruva SS, Ross JS, Rathi VK. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. 2020. PMID: 33044513
Dhruva SS, Shah ND, Ross JS. Mandatory Registration and Results Reporting of Real-World Evidence Studies of FDA-Regulated Medical Products. 2020. PMID: 33289654
Mori M, Brooks C, Spatz E, Mortazavi BJ, Dhruva SS, Linderman GC, Grab LA, Zhang Y, Geirsson A, Chaudhry SI, Krumholz HM. Protocol for project recovery after cardiac surgery: a single-center cohort study leveraging digital platform to characterise longitudinal patient-reported postoperative recovery patterns. 2020. PMID: 32873671
Johnston JL, Dhruva SS, Ross JS, Rathi VK. Early experience with the FDA's Breakthrough Devices program. 2020. PMID: 32704171
Saleem N, Ismail MK, Tombazzi CR, Soin S, Dhruva SS. Endoscopic transmission of carbapenem-resistant Enterobacteriaceae: implications for Food and Drug Administration approval and postmarket surveillance of endoscopic devices. 2020. PMID: 32750323
Dhruva SS, Mortazavi BJ, Desai NR. Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump for Cardiogenic Shock-Reply. 2020. PMID: 32692385
Dhruva SS, Ross JS, Akar JG, Caldwell B, Childers K, Chow W, Ciaccio L, Coplan P, Dong J, Dykhoff HJ, Johnston S, Kellogg T, Long C, Noseworthy PA, Roberts K, Saha A, Yoo A, Shah ND. Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform. 2020. PMID: 32352038
Wray CM, Dhruva SS, Dhaliwal G. The Art of the Deal: Negotiating Consult Conflict. 2020. PMID: 32311342
Resnic FS, Majithia A, Dhruva SS, Ssemaganda H, Robbins S, Marinac-Dabic D, Hewitt K, Ohno-Machado L, Reynolds MR, Matheny ME. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures. 2020. PMID: 32283971
Ross JS, Dhruva SS, Shah ND. Commentary on Bertagnolli et al.: Leveraging electronic health record data for clinical trials-a brave new world. 2020. PMID: 32266836
Money NM, Schroeder AR, Quinonez RA, Ho T, Marin JR, Morgan DJ, Dhruva SS, Coon ER. 2019 Update on Pediatric Medical Overuse: A Systematic Review. 2020. PMID: 32011675
Dhruva SS, Redberg RF. A Successful but Underused Strategy for Reducing Low-Value Care: Stop Paying for It. 2020. PMID: 32040167
Solotke MT, Liu P, Dhruva SS, Gulanski B, Shah ND, Ross JS. Medicare Prescription Drug Plan Coverage of Hormone Therapies Used by Transgender Individuals. 2020. PMID: 32267818
Bartlett VL, Liu P, Dhruva SS, Shah ND, Bollinger KE, Ross JS. Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017. 2020. PMID: 32223594
Liu P, Dhruva SS, Shah ND, Ross JS. Medicare beneficiaries' out-of-pocket costs for commonly used generic drugs, 2009-2017. 2020. PMID: 32181626
Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, Ngufor C, Girotra S, Amin AP, Shah ND, Desai NR. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. 2020. PMID: 32040163
Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D, Sedrakyan A, Normand ST, Krumholz HM, Ross JS. Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data. 2020. PMID: 32063087
Robinson JC, Whaley C, Brown TT, Dhruva SS. Physician and Patient Adjustment to Reference Pricing for Drugs. 2020. PMID: 32022881
Liu P, Ross JS, Ioannidis JP, Dhruva SS, Vasiliou V, Wallach JD. Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews. 2019. PMID: 31709809
Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2019 Update on Medical Overuse: A Review. 2019. PMID: 31498374
Solotke MT, Ross JS, Shah ND, Karaca-Mandic P, Dhruva SS. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings. 2019. PMID: 31663461
Egilman AC, Wallach JD, Dhruva SS, Gonsalves GS, Ross JS. Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment Agencies. 2019. PMID: 31313117
Liu P, Ioannidis JPA, Ross JS, Dhruva SS, Luxkaranayagam AT, Vasiliou V, Wallach JD. Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study. 2019. PMID: 31639007
Vijay A, Gupta R, Liu P, Dhruva SS, Shah ND, Ross JS. Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics. 2019. PMID: 31625043
Bartlett VL, Dhruva SS, Shah ND, Ryan P, Ross JS. Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence. 2019. PMID: 31596493
Kahn PA, Dhruva SS, Rhee TG, Ross JS. Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016. 2019. PMID: 31617923
Dayoub EJ, Ross JS, Shah ND, Dhruva SS. Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates. 2019. PMID: 31567008
DuBose-Briski V, Yao X, Dunlay SM, Dhruva SS, Ross JS, Shah ND, Noseworthy PA. Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment. 2019. PMID: 31566106
Redberg RF, Dhruva SS. Moving From Substantial Equivalence to Substantial Improvement for 510(k) Devices. 2019. PMID: 31355877
Shahu A, Herrin J, Dhruva SS, Desai NR, Davis BR, Krumholz HM, Spatz ES. Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT. 2019. PMID: 31362591
Shaw LJ, Blankstein R, Brown DL, Dhruva SS, Douglas PS, Genders TSS, Gibbons RJ, Greenwood JP, Kwong R, Leipsic J, Mahmarian JJ, Maron D, Nagel E, Nicol E, Nieman K, Pellikka PA, Redberg RF, Weir-McCall J, Williams MC, Chandrasekhar Y. Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes. 2019. PMID: 31272608
Judson TJ, Dhruva SS, Redberg RF. Evaluation of technologies approved for supplemental payments in the United States. 2019. PMID: 31209124
Wallach JD, Luxkaranayagam AT, Dhruva SS, Miller JE, Ross JS. Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis. 2019. PMID: 31203816
Skydel JJ, Luxkaranayagam AT, Dhruva SS, Ross JS, Wallach JD. Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments. 2019. PMID: 31074812
Morgan DJ, Dhruva SS, Korenstein D. Clinical Interpretation of High-Sensitivity Troponin Testing-Reply. 2019. PMID: 31058941
Coon ER, Quinonez RA, Morgan DJ, Dhruva SS, Ho T, Money N, Schroeder AR. 2018 Update on Pediatric Medical Overuse: A Review. 2019. PMID: 30776069
Vijay A, Ross JS, Shah ND, Jeffery MM, Dhruva SS. Medicare Formulary Coverage and Restrictions for Opioid Potentiators from 2013 to 2017. 2019. PMID: 30623386
Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2018 Update on Medical Overuse. 2018. PMID: 30508032
Dhruva SS. Implementation of an EConsult System with Patient Navigation. 2019. PMID: 30827966
Shaw DL, Dhruva SS, Ross JS. Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval. 2018. PMID: 30479199
Huang C, Murugiah K, Mahajan S, Li SX, Dhruva SS, Haimovich JS, Wang Y, Schulz WL, Testani JM, Wilson FP, Mena CI, Masoudi FA, Rumsfeld JS, Spertus JA, Mortazavi BJ, Krumholz HM. Enhancing the prediction of acute kidney injury risk after percutaneous coronary intervention using machine learning techniques: A retrospective cohort study. 2018. PMID: 30481186
Dhruva SS, Ross JS, Desai NR. Alirocumab's Price Reduction. 2018. PMID: 30354510
Jones LC, Dhruva SS, Redberg RF. Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program. 2018. PMID: 30178044
Roginiel AC, Dhruva SS, Ross JS. Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study. 2018. PMID: 30290675
Sedrakyan A, Dhruva SS, Sun T, Mao J, Gaudino MFL, Redberg RF. Trends in Use of Transcatheter Aortic Valve Replacement by Age. 2018. PMID: 30039166
Welsh J, Lu Y, Dhruva SS, Bikdeli B, Desai NR, Benchetrit L, Zimmerman CO, Mu L, Ross JS, Krumholz HM. Age of Data at the Time of Publication of Contemporary Clinical Trials. 2018. PMID: 30646100
Dhruva SS, Ross JS, Desai NR. Real-World Evidence: Promise and Peril For Medical Product Evaluation. 2018. PMID: 30100687
Liu P, Dhruva SS, Shah ND, Ross JS. Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs. 2018. PMID: 30039170
Warner F, Dhruva SS, Ross JS, Dey P, Murugiah K, Krumholz HM. Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population. 2018. PMID: 30037874
Dhruva SS. Continuing to Improve Appropriateness of Continuous Electrocardiographic Monitoring (Telemetry). 2018. PMID: 29868799
Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li SX, Marinac-Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS. Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators. 2018. PMID: 29896873
Dhruva SS, Ross JS, Schulz WL, Krumholz HM. Fulfilling the Promise of Unique Device Identifiers. 2018. PMID: 29868760
Wallach JD, Egilman AC, Dhruva SS, McCarthy ME, Miller JE, Woloshin S, Schwartz LM, Ross JS. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis. 2018. PMID: 29794072
Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR. 2017 Update on Pediatric Medical Overuse: A Review. 2018. PMID: 29582079
Egilman AC, Wallach JD, Ross JS, Dhruva SS. Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015. 2018. PMID: 29340562
Morgan DJ, Dhruva SS, Korenstein D. Medical Overuse of Prostate-Specific Antigen Testing and Overprescription of Antibiotics-Reply. 2018. PMID: 29507989
Morgan DJ, Dhruva SS, Coon ER, Wright SM, Korenstein D. 2017 Update on Medical Overuse: A Systematic Review. 2018. PMID: 28973402
Solotke MT, Dhruva SS, Downing NS, Shah ND, Ross JS. New and incremental FDA black box warnings from 2008 to 2015. 2017. PMID: 29215916
Huang C, Dhruva SS, Coppi AC, Warner F, Li SX, Lin H, Nasir K, Krumholz HM. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results. 2017. PMID: 29133522
Foy AJ, Dhruva SS, Peterson B, Mandrola JM, Morgan DJ, Redberg RF. Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis. 2017. PMID: 28973101
Dhruva SS, Curtis JP. Requiem for a Scaffold. 2017. PMID: 29049832
Samuels EA, Ross JS, Dhruva SS. Medicare Formulary Coverage Restrictions for Prescription Opioids, 2006 to 2015. 2017. PMID: 29052693
Angraal S, Ross JS, Dhruva SS, Desai NR, Welsh JW, Krumholz HM. Merits of Data Sharing: The Digitalis Investigation Group Trial. 2017. PMID: 28958337
Gupta R, Dhruva SS, Fox ER, Ross JS. The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States. 2017. PMID: 28944731
Dhruva SS, Karaca-Mandic P, Shah ND, Shaw DL, Ross JS. Association between FDA black box warnings and Medicare formulary coverage changes. 2017. PMID: 29087169
Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR. Author's Response. 2017. PMID: 28860137
Dhruva SS, Mazure CM, Ross JS, Redberg RF. Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices. 2017. PMID: 28738116
Zheng SY, Dhruva SS, Redberg RF. Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements. 2017. PMID: 28810022
Dhruva SS, Huang C, Spatz ES, Coppi AC, Warner F, Li SX, Lin H, Xu X, Furberg CD, Davis BR, Pressel SL, Coifman RR, Krumholz HM. Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). 2017. PMID: 28559399
Dhruva SS, Redberg RF. FDA Drug Trials Snapshots-A Clearer Picture. 2017. PMID: 28288250
Krumholz HM, Dhruva SS. Real-World Data on Heart Failure Readmission Reduction: Real or Real Uncertain? 2017. PMID: 28330750
Sedrakyan A, Dhruva SS, Shuhaiber J. Transcatheter Aortic Valve Replacement in Younger Individuals. 2017. PMID: 28027340
Dhruva SS, Desai NR, Karaca-Mandic P, Shah ND, Ross JS. Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline. 2017. PMID: 28081832
Coon ER, Young PC, Quinonez RA, Morgan DJ, Dhruva SS, Schroeder AR. Update on Pediatric Overuse. 2017. PMID: 28049113
Morgan DJ, Dhruva SS, Wright SM, Korenstein D. 2016 Update on Medical Overuse: A Systematic Review. 2016. PMID: 27654002
Foy AJ, Dhruva SS, Mandrola J. For the Patient with "Low-risk Chest Pain"-How Low Is Low? 2016. PMID: 27671908
Dhruva SS, Redberg RF. Sex-Specific Data for the Subcutaneous Implantable Cardioverter-Defibrillator. 2016. PMID: 27364060
Dhruva SS, Krumholz HM. Championing Effectiveness Before Cost-Effectiveness. 2016. PMID: 27039130
Dhruva SS, Prasad V. Application of Medicare's New Technology Add-on Payment Program for Blinatumomab. 2016. PMID: 26720844
Dhruva SS, Krumholz HM. The Core Value of Cost-Effectiveness Analyses. 2016. PMID: 26764064
Morgan DJ, Dhruva SS, Wright SM, Korenstein D. Update on Medical Practices That Should Be Questioned in 2015. 2015. PMID: 26551354
Dhruva SS, Ross JS, Gariepy AM. Revisiting Essure--Toward Safe and Effective Sterilization. 2015. PMID: 26397951
Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG. Setting a research agenda for medical overuse. 2015. PMID: 26306661
Sab S, Dhruva SS, Paulsen J, Sidhu RS, Amsterdam EA, Venugopal S. Here Today, Gone Tomorrow. 2015. PMID: 26302138
Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. 2015. PMID: 26063311
Dhruva SS, Redberg RF. Evidence And Medicare's Coverage Of Interventions. 2015. PMID: 26056214
Morgan DJ, Wright SM, Dhruva S. Update on medical overuse. 2015. PMID: 25365707
Gartenberg AJ, Peleg A, Dhruva SS, Redberg RF. Presumed safe no more: lessons from the Wingspan saga on regulation of devices. 2014. PMID: 24452627
Baxi S, Platts-Mills J, Dhruva S, Huang L, Hanks D, Dhaliwal G. A double-edged sword. 2013. PMID: 23293015
Dhruva SS, Redberg RF. FDA regulation of cardiovascular devices and opportunities for improvement. 2012. PMID: 23263896
Chen CE, Dhruva SS, Redberg RF. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. 2012. PMID: 23117769
Dhruva SS, Redberg RF. Medical device regulation: time to improve performance. 2012. PMID: 22859912
Dhruva SS, Redberg RF. Evaluating sex differences in medical device clinical trials: time for action. 2012. PMID: 22378695
Dhruva SS, Redberg RF. Withdrawing unsafe drugs from the market. 2011. PMID: 22068420
Dhruva SS, Redberg RF. Sex-specific outcomes for HeartMate II. 2011. PMID: 21903068
Redberg RF, Dhruva SS. Transcatheter aortic-valve replacement. 2011. PMID: 21899458
Dhruva SS, Redberg RF. Clinical trial enrollment and progress in women's health. 2011. PMID: 21427370
Dhruva SS, Bero LA, Redberg RF. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices. 2011. PMID: 21364127
Redberg RF, Dhruva SS. Medical device recalls: get it right the first time: Comment on "Medical device recalls and the FDA approval process". 2011. PMID: 21321286
Chen CE, Dhruva SS, Bero LA, Redberg RF. Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies. 2010. PMID: 21098342
Dhruva SS, Redberg RF. Accelerated approval and possible withdrawal of midodrine. 2010. PMID: 21081731
Dhruva SS, Redberg RF. The need for sex-specific data prior to food and drug administration approval. 2010. PMID: 20117414
Dhruva SS, Bero LA, Redberg RF. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. 2009. PMID: 20040556
Dhruva SS, Phurrough SE, Salive ME, Redberg RF. CMS's landmark decision on CT colonography--examining the relevant data. 2009. PMID: 19474419
Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. 2008. PMID: 18227358
Munshi C, Dhamee S, Bardeen-Henschel A, Dhruva S. Recognition of mixed anesthetic agents by mass spectrometer during anesthesia. 1986. PMID: 3711948